UNSPSC 51152055: Dotefonium bromide

This classification denotes a muscle relaxant with the molecular formula C20H27N2O2S.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D762286A5N, chemically known as pyrrolidinium, 1-methyl-1-(2-(n-methyl-alpha-2-thienylmandelamido)ethyl)-, bromide but more generally known as dotefonium bromide, which bears US NIH Compound Identifier 71913. European Medicines Agency schedules Dotefonium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06379MIG.

UNSPSC 51152055 Dotefonium bromide (Commodity) does not align with the recent state and local procurement activity tagged under this code. The single recent opportunity on file—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems for community health initiatives, not dotefonium bromide. The sourcing and scope mismatch suggests this code sees minimal relevant activity in the state and local market, or that tagging errors are routing unrelated health-sector procurements to a pharmaceutical intermediate product code.

The Seminole County IFB calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year initial term with one-year renewal option, with quarterly deliveries to the county community health building and all shipping included in vendor pricing. The notice closed July 26, 2023 (a date that predates the posting date by nearly three years, indicating a data quality issue in the source). Without additional recent opportunities under this code, geographic concentration and repeat buyer patterns cannot be characterized. Firms evaluating this Commodity code should verify whether their product or service actually maps to dotefonium bromide, or whether state and local purchasing under this UNSPSC classification is currently dormant.